Correlation Between Molecular Partners and ImmuCell
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and ImmuCell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and ImmuCell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and ImmuCell, you can compare the effects of market volatilities on Molecular Partners and ImmuCell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of ImmuCell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and ImmuCell.
Diversification Opportunities for Molecular Partners and ImmuCell
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and ImmuCell is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and ImmuCell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmuCell and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with ImmuCell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmuCell has no effect on the direction of Molecular Partners i.e., Molecular Partners and ImmuCell go up and down completely randomly.
Pair Corralation between Molecular Partners and ImmuCell
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.79 times more return on investment than ImmuCell. However, Molecular Partners is 1.79 times more volatile than ImmuCell. It trades about 0.02 of its potential returns per unit of risk. ImmuCell is currently generating about 0.01 per unit of risk. If you would invest 592.00 in Molecular Partners AG on November 29, 2024 and sell it today you would lose (107.00) from holding Molecular Partners AG or give up 18.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. ImmuCell
Performance |
| Timeline |
| Molecular Partners |
| ImmuCell |
Molecular Partners and ImmuCell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and ImmuCell
The main advantage of trading using opposite Molecular Partners and ImmuCell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, ImmuCell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmuCell will offset losses from the drop in ImmuCell's long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| ImmuCell vs. Transgene SA | ImmuCell vs. Fennec Pharmaceuticals | ImmuCell vs. Lipella Pharmaceuticals Common | ImmuCell vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |